Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hallal David
Relationship:   Director
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   2,920,473    

Indirect Shares

   17,647,006      
Direct Value   $38,917,709    

Indirect Value

   $33,839,013      
Total Shares   20,567,479      
Total Value   $72,756,722      


Alexion Pharmaceuticals Inc $34,541,045 Scholar Rock Holding Corp $2,763,558 Allovir Inc $1,613,106 Seer, Inc. $0 Alexion Pharmaceuticals Inc $34,541,045 Scholar Rock Holding Corp $2,763,558 Allovir Inc $1,613,106 Seer, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -113.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN CEO, Director 2016-08-08 189,266 2014-12-18 113,122    Premium*  
            Scholar Rock Holding Corp SRRK Director 2019-09-18 290,595 2019-09-18 0    Premium*  
            Allovir Inc ALVR 2024-06-06 2,143,662 2024-06-06 17,533,884    Premium*  
            Seer, Inc. SEER Director 2023-06-14 296,950 0    Premium*  
            Iteos Therapeutics, Inc. ITOS Director 2022-06-09 0 2021-12-20 0    Premium*  
* Premium Members only  

Records found :    128         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... SVP, Global Commercial Ops   •       –      –    2012-06-15 4 OE $11.92 $170,551 D/D 14,308 77,518 0 -
ALXN Alexion Pharmaceuticals I... SVP. Global Commercial Ops   •       –      –    2012-07-27 4 OE $17.65 $882,500 D/D 50,000 113,210 0 -
ALXN Alexion Pharmaceuticals I... SVP. Global Commercial Ops   •       –      –    2012-10-24 4 OE $8.16 $85,680 D/D 10,500 72,475 0 -
ALXN Alexion Pharmaceuticals I... SVP. Global Commercial Ops   •       –      –    2012-10-24 4 OE $8.16 $85,680 D/D 10,500 72,475 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-06-05 4 OE $8.16 $204,281 D/D 15,008 89,654 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-07-12 4 OE $17.65 $882,500 D/D 50,000 139,654 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-10-28 4 OE $17.98 $539,400 I/I 30,000 118,178 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-10-28 4 OE $17.98 $323,640 D/D 18,000 106,178 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-09 4 OE $17.98 $263,173 I/I 14,637 124,315 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-09 4 OE $17.98 $192,476 D/D 10,705 120,383 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-18 4 OE $17.98 $131,164 D/D 7,295 116,973 0 -
ALXN Alexion Pharmaceuticals I... Chief Operating Officer   •       •      –    2014-11-03 4 OE $17.65 $611,736 D/D 30,000 148,616 0 -
ITOS Iteos Therapeutics, Inc. Director   –       •      –    2021-12-20 4 OE $2.95 $174,500 D/D 50,000 50,000 0 -
ITOS Iteos Therapeutics, Inc. Director   –       •      –    2022-06-08 4 OE $2.95 $105,087 D/D 28,444 10,577 0 -
ITOS Iteos Therapeutics, Inc. Director   –       •      –    2022-06-09 4 OE $4.23 $4,953 D/D 1,171 1,171 0 -
ALXN Alexion Pharmaceuticals I... Sr. VP Comm. Ops, Americas   •       –      –    2009-06-11 4 S $38.00 $136,420 D/D (3,590) 19,910 0 -
ALXN Alexion Pharmaceuticals I... Sr. VP Comm Ops, Americas   •       –      –    2009-06-19 4 S $38.47 $30,353 D/D (789) 19,121 0 -
ALXN Alexion Pharmaceuticals I... Sr. VP Comm Ops, Americas   •       –      –    2009-07-16 4 S $38.96 $9,272 D/D (238) 18,883 0 -
ALXN Alexion Pharmaceuticals I... Sr. VP Comm Ops, Americas   •       –      –    2009-07-27 4 S $43.00 $371,520 D/D (8,640) 10,243 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2009-12-11 4 S $46.40 $464,000 D/D (10,000) 10,243 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2009-12-21 4 S $47.79 $43,776 D/D (916) 9,327 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2010-01-11 4 S $47.78 $51,985 D/D (1,088) 8,239 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2010-01-19 4 S $47.22 $10,719 D/D (227) 8,012 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2010-02-16 4 S $47.93 $299,179 D/D (6,242) 7,770 0 -
ALXN Alexion Pharmaceuticals I... SVP Commercial Ops, Americas   •       –      –    2010-03-02 4 S $51.80 $518,000 D/D (10,000) 7,770 0 -
  128  Records found
  1   2   3  4   5   6      
  Page 3 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us